Effect of postoperative positive airway pressure on risk of postoperative atrial fibrillation after cardiac surgery in patients with obstructive sleep apnea: a retrospective cohort study by unknown
Sleep Science and PracticeDing et al. Sleep Science and Practice  (2017) 1:5 
DOI 10.1186/s41606-016-0004-1RESEARCH Open AccessEffect of postoperative positive airway
pressure on risk of postoperative atrial
fibrillation after cardiac surgery in patients
with obstructive sleep apnea: a
retrospective cohort study
Feihong Ding1, Jimmy Kar-Hing Wong2, Alice S. Whittemore3 and Clete A. Kushida1*Abstract
Background: Obstructive sleep apnea (OSA) is a known risk factor for postoperative atrial fibrillation (POAF) after
cardiac surgery. However, whether better management of OSA reduces the risk of POAF remains unknown. The aim
of this study was to determine if postoperative positive airway pressure (PAP) treatment for OSA reduces POAF risk
after cardiac surgery. PAP included both continuous and bilevel positive airway pressure.
Methods: This retrospective cohort study was conducted at Stanford University teaching hospital. We included a
total of 152 OSA patients with preoperative electrocardiography showing sinus rhythm who underwent coronary
artery bypass grafting (CABG), aortic valve replacement, mitral valve repair/replacement, or combined valve and
CABG surgery from October 2007 to September 2014. Postoperative PAP use status was determined by reviewing
electronic health records. The primary outcome was time to incident POAF. We reviewed records from the time of
surgery to hospital discharge. Multivariate Cox regression model was used to calculate the adjusted hazard ratio of
postoperative PAP in association with risk of POAF.
Results: Of the 152 OSA patients included for analysis, 86 (57%) developed POAF, and 76 (50%) received
postoperative PAP treatment. POAF occurred in 37 (49%) of the patients receiving postoperative PAP, compared
with 49 (65%) of those not receiving postoperative PAP (unadjusted p value = 0.33). Multivariable Cox regression
analysis of time to incident POAF did not show an association between postoperative PAP treatment and risk of
POAF (adjusted hazard ratio: 0.93 [95%CI: 0.58 – 1.48]). There were no significant differences in other postoperative
complications between the two groups.
Conclusions: The study did not find an association between postoperative PAP treatment and risk of POAF after
cardiac surgery in patients with OSA. Future prospective randomized trials are needed to investigate this issue further.
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Postoperative atrial fibrillation (POAF) is a common com-
plication following cardiac surgery, affecting 30% to 50%
of patients (Yadava et al. 2014). Although generally well-
tolerated and self-resolving, POAF is associated with
multiple adverse outcomes: increased risk of stroke, in-
creased short- and long-term mortality, prolonged hospi-
talizations, increased cost of care, and late recurrence of
atrial fibrillation (Horwich et al. 2013; Phan et al. 2015;
LaPar et al. 2014; Ahlsson et al. 2010). Multiple risk
factors—including advanced age, previous atrial fibrilla-
tion, valve surgery, chronic obstructive pulmonary disease,
and perioperative withdrawal of beta-blockers—are associ-
ated with POAF after cardiac surgery (Mathew et al.
2004), but few are modifiable. Several studies have shown
that obstructive sleep apnea (OSA), with an estimated
prevalence of up to 80% in the cardiac surgical population
(Zhao et al. 2015), is an independent risk factor for POAF
(Zhao et al. 2015; Wong et al. 2015; Uchôa et al. 2015; van
Oosten et al. 2014; Qaddoura et al. 2014). However,
whether OSA is a modifiable risk factor for POAF after
cardiac surgery is unknown.
The most effective OSA treatments are continuous posi-
tive airway pressure (CPAP) or bilevel positive airway
pressure (BPAP) (the term “positive airway pressure” or
PAP denotes either CPAP or BPAP in this study). In non-
surgical OSA patients, PAP therapy has been shown to
reduce the recurrence rate of atrial fibrillation (QureshiFig. 1 Cohort-building Diagram. 1Study included only patients who underw
2Electrocardiography. 3Obstructive sleep apnea. 4Postoperative positive airwet al. 2015). However, no studies have investigated the
effect of postoperative PAP on POAF after cardiac surgery.
Given the poor adherence to PAP treatment of OSA
patients at home (Stepnowsky & Moore 2003), the post-
operative period after cardiac surgery may provide an ideal
opportunity for physicians to use PAP to reduce the risk
of POAF in OSA patients. Therefore, this retrospective
cohort study aimed to determine if postoperative PAP
reduces POAF risk after cardiac surgery in OSA patients.
Methods
Study population
We included OSA patients who underwent coronary artery
bypass grafting (CABG), aortic valve replacement, mitral
valve replacement/repair, or combined valve and CABG
surgery requiring cardiopulmonary bypass performed at
Stanford University from October 2007 to September 2014.
We reviewed electronic medical charts of consecutive
patients. Cardiac parameters including atrial fibrillation
history and POAF, and sleep-related data including OSA
history and post-operative PAP use were reviewed by two
different investigators. We considered patients to have
OSA if: 1) two independent sources documented a prior
diagnosis of OSA, 2) one source documented a prior
diagnosis of OSA with explicit documentation of whether
the patient was using nocturnal PAP, or 3) a sleep study in
the medical record documented OSA (Wong et al. 2015).
We considered patients to have received postoperative PAPent coronary artery bypass grafting and/or valve surgeries.
ay pressure. 5Postoperative atrial fibrillation
Table 1 Descriptive Characteristics of the Study Groups, mean






N 76 (50) 76 (50)
Age (yrs.) 67.3 ± 10.4 63.7 ± 12.1 0.05
Male 53 (69.7) 64 (84.2) 0.03
White 53 (69.7) 56 (73.7) 0.59
Body Mass Index (kg/m2) 32.1 ± 7.6 32.1 ± 7.1 0.99
Comorbidities
Previous Atrial Fibrillation 16 (21.1) 16 (21.1) 1.00
Previous Cerebrovascular
Eventc
13 (17.1) 5 (6.6) 0.05
Previous Myocardial
Infarction
16 (21.1) 6 (7.9) 0.02
COPDd 11 (14.5) 5 (6.6) 0.11
Hypertension 63 (82.9) 59 (77.6) 0.42
Hyperlipidemia 50 (65.8) 51 (67.1) 0.86
Perioperative Characteristics
Elective Surgery 69 (90.8) 67 (88.2) 0.60
Valve Surgery 44 (57.9) 47 (61.8) 0.62
Preoperative IABPe 2 (2.6) 0 (0) 0.50
CPB timef (mins) 153.9 ± 59.3 174.4 ± 79.7 0.07
Aortic Cross-Clamp
time (mins)
103.9 ± 44.7 121.2 ± 62.3 0.05
Post operative day
of extubation
0.5 ± 0.8 0.6 ± 1.0 0.68
Home PAP use 17 (22.4) 62 (81.6) <0.0001
aPositive airway pressure
bStudent t tests, Chi-square tests or Fisher’s exact tests were used to calculate
the p value
cCerebrovascular Event includes cerebral vascular accident and transient
ischemic attack
dChronic obstructive pulmonary disease
eIntra-aortic balloon counterpulsation pump
fCardiopulmonary bypass time
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mented use of nocturnal PAP after extubation and before
the onset of POAF; and 2) follow-up documentation con-
firmed PAP use at least one night before hospital discharge.Primary outcome
The primary outcome was time to incident POAF. We de-
fined POAF as atrial fibrillation requiring either pharma-
cologic treatment or direct current cardioversion after
initial extubation from cardiac surgery and before dis-
charge from hospital. We determined the timing of POAF
by reviewing physicians and nurses’ notes, pharmacy
records, procedural notes, electrocardiography (EKG) and
telemetry strips. All cardiac surgery patients were on
telemetry monitoring for their entire hospitalization.Statistical analysis
We tested differences in demographic variables, comor-
bidities, and perioperative characteristics using t-tests for
continuous variables and chi-square tests or Fisher’s exact
tests for categorical variables. All tests were two-tailed.
We considered variables to be statistically significant if
they attained a p value of <0.05.
We treated postoperative PAP treatment as a time
dependent variable in a multivariate Cox regression model.
Because we lacked data on intermittent postoperative PAP
use, we assumed that PAP treatment continued until
discharge once it started. The regression model included
covariates that differed in bivariate analyses (p ≤ 0.1) or that
had previously been identified as potential confounders.
We checked the proportional hazard assumption with log-
log plots. All statistical analyses were performed using SAS
version 9.4 (SAS Institute, Cary, NC).
This retrospective cohort study was approved by our
Institutional Review Board. The requirement to obtain
individual consent was waived because the data were
collected retrospectively.Results
We reviewed a total of 284 patient records. After excluding
132 patients for various reasons (Fig. 1), there were 152
patients eligible for study. Exactly half of the 152 eligible
patients (N = 76) received postoperative PAP treatment.
Home PAP use was a strong predictor for postoperative
PAP treatment (Table 1). 62 patients (82%) among those
who received postoperative PAP had used PAP at home pre-
operatively, compared with 17 patients (22%) among those
who did not receive postoperative PAP. Compared with pa-
tients who did not receive postoperative PAP, patients who
received postoperative PAP were younger, more likely to be
male, had a significantly lower proportion of preoperative
comorbidities including history of cerebrovascular events
and myocardial infarction, and had a significantly longer
cardiopulmonary bypass time and aortic cross-clamp time.
As shown in Table 1, we observed no differences between
the two groups in body mass index, previous atrial fibrilla-
tion, or postoperative day of extubation.
Among patients who received postoperative PAP treat-
ment, 33 (43%) started treatment immediately on the day
of cardiac surgery, and 55 patients (72%) started within the
first day after surgery. The remaining patients started post-
operative PAP on postoperative day 2 to day 10 (Fig. 2a).
Eighty-six patients (57%) developed POAF after cardiac
surgery. The majority of POAF cases occurred in the 3-
day period from postoperative day 2 to day 4, with a peak
incidence on day 2. POAF occurred slightly later among
patients who received postoperative PAP than that among
those who did not, but the difference was not statistically
significant (Fig. 2b).
ab
Fig. 2 a Distribution of Postoperative Day of Initial Positive Pressure Airway Treatment Among 76 Patients. b Distribution of Postoperative Day of
Incident Atrial Fibrillation.1 p =0.20 for test of no difference in days of incident postoperative atrial fibrillation
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confidence intervals obtained from a multivariable Cox
regression model. Thirty-seven (49%) of the 76 patients
receiving postoperative PAP treatment developed POAF,
compared with 49 (65%) of the 76 patients without post-
operative PAP treatment. As seen in Fig. 3 and Table 2,
analysis of time to incident POAF did not show an asso-
ciation between postoperative PAP treatment and POAF
risk (adjusted hazard ratio: 0.93 [95% CI: 0.58 – 1.48]).
In contrast, we observed a significant increase in POAF
risk among older patients (adjusted hazard ratio for 10-
year increase in age: 1.30 [95% CI: 1.04 – 1.61]) and
those with a prior history of atrial fibrillation (adjusted
hazard ratio: 2.34 [95% CI: 1.42 – 3.86]).We did not find an effect of postoperative PAP treat-
ment on other postoperative complications such as rein-
tubation, ICU readmission, length of initial ICU stay or
hospital stay (Table 3).
Discussion
POAF remains a common complication after cardiac sur-
gery. Multiple risk factors have been identified, but few
are modifiable. We hypothesized that PAP after cardiac
surgery reduces the risk of POAF in patients with OSA.
OSA has been associated with increased risk of POAF
after cardiac surgery. Several pathophysiologic mechanisms
may contribute to the relationship between OSA and atrial
fibrillation: sudden and repeated swings in intra-thoracic
Fig. 3 Forest Plot of Multivariate Cox Regression Model. 1 We treated postoperative positive airway pressure use as a time-dependent variable in
the multivariate Cox regression model. The PAP variable for patients who received postoperative PAP was coded as zero until the start of PAP
and as one thereafter. 2 10-year increase. 3 Chronic obstructive pulmonary disease. 4 60-min increase
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systemic inflammation, and instability of autonomic tone as-
sociated with intermittent hypoxia or hypercapnia (Hohl
et al. 2014; Orban et al. 2008; Neilan et al. 2013; Stevenson
et al. 2010). In non-surgical OSA patients, PAP treatment
reduces or abolishes hypopnea and apnea episodes, reverses
cardiac remodeling, mitigates systemic inflammation and re-
duces atrial fibrillation recurrence risk in patients with prior
atrial fibrillation history (Qureshi et al. 2015; Neilan et al.
2013; Xie et al. 2013). It follows, therefore, that PAP treat-
ment after cardiac surgery may reduce the risk of POAF.
In this analysis, we did not find an association between
postoperative PAP therapy and POAF risk. One concern
is misclassification of postoperative PAP use. PAP use
was determined by physicians or nurses’ notes rather
than objective device adherence data, which could lead
to misclassification because nightly PAP use cannot be
objectively confirmed. This misclassification may bias
the association between postoperative PAP treatment





POAF 49 (64.5%) 37 (48.7%)
aWe treated postoperative PAP use as a time-dependent variable in the Cox regress
coded as zero until the start of PAP and as one thereafter
bAdjusted for age, gender, previous atrial fibrillation, history of cerebrovascular eve
surgery type, cardiopulmonary bypass time, and aortic cross-clamp timeUnmeasured potential confounders are another con-
cern. Patients who received post-operative PAP treatment
and who did not differed in several baseline and peri-
operative characteristics such as previous history of myo-
cardial infarction and length of aortic cross-clamp time
(Table 1). Although we adjusted for all these measured po-
tential confounders in the multivariate Cox regression
model, the concern for unmeasured potential confounders
remains. For example, perioperative medication use may
differ between those who did or did not receive postopera-
tive PAP therapy, and also be related to POAF risk
(Mathew et al. 2004). Other limitations include the lack of
OSA severity data and the high correlation between home
and postoperative PAP use. This correlation complicates
the determination of whether any reduction in POAF risk
reflects home PAP use, postoperative PAP use, or both.
Nevertheless, we are unaware of previous studies explor-
ing the effect of postoperative PAP administration on risk
of POAF after cardiac surgery in OSA patients. Few studies





0.81 (0.53 – 1.24) 0.93 (0.58 – 1.48)
ion model. The PAP variable for patients who received postoperative PAP was
nt, history of myocardial infarction, chronic obstructive pulmonary disease,
Table 3 Other Postoperative Complications in Relation to




















4 (5.3) 2 (2.6) 0.49
(0.09 –2.74)
Reinbutation 4 (5.3) 7 (9.2) 1.83
(0.51 – 6.52)
Tracheostomy 0 1 (1.3)













4 (5.3) 2 (2.6) 0.49
(0.09 – 2.74)









29 (38.2) 24 (31.6) 0.75
(0.38 – 1.46)
Length of Stay as Continuous Variable, Median (IQR)
Initial ICU Length
of Stay (days)
3 (2 – 5) 2 (2 – 4.5)
Hospital Length
of Stay (days)
8 (7 – 12) 8 (6 – 12.5)
aPulmonary embolus and/or deep vein thrombosis as indicated by
radiographic (including ultrasound) or autopsy
bIntensive care unit
cThe period between immediate postoperative care to discharge to telemetry
unit, not including ICU readmission days
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tive complications but with inconsistent results (Nagappa
et al. 2015; Liao et al. 2013). Given the difficulty in reliably
determining the postoperative PAP use, the only way to
answer this question might be a prospective randomized
trial with a clearly defined protocol.
Conclusions
This is the first study to examine the effect of postopera-
tive PAP treatment on the risk of POAF after cardiac
surgery in patients with OSA. We did not find a reduc-
tion in POAF occurrence after cardiac surgery in OSA
patients given postoperative PAP. However, given the
limitations of this study, postoperative PAP should con-
tinue to be recommended in OSA patients until future
prospective randomized trials with more rigorous data
collection can be performed to further clarify this issue.Abbreviations
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